Wireless Device Monitors Oxygen Levels Remotely
|
By HospiMedica International staff writers Posted on 06 Feb 2020 |
|
Image: The wireless Lumee optical reader (Photo courtesy of Profusa)
A novel sensing platform provides continuous, real-time monitoring of tissue oxygen in patients with potential acute and/or chronic changes in tissue oxygen levels.
The Profusa (Emeryville, CA, USA) Wireless Lumee Oxygen platform consists of a tiny biosensor injected in the upper arm, shoulder, or leg for continuous and long-term monitoring of oxygen in subcutaneous tissue; and a low profile, lightweight wireless optical reader that adheres to the skin, which reads the fluorescent signal from the biosensor and transmits the data to a tablet, which displays real-time data visualization using the proprietary Lumee app. The data monitored includes changes in oxygen levels, comparison of the patient's current data with historical data from a clinical registry study, and a data report.
The data outputs allow physicians to monitor compromised tissue in conditions such as peripheral artery disease (PAD) and critical limb ischemia (CLI), as well as to compare a patient's oxygen levels before, during, and after an endovascular procedure. In contrast to external pulse oximeters, which measure oxygen bound to the hemoglobin in larger blood vessels, it measures dissolved oxygen at the tissue level in interstitial fluid. The Lumee Oxygen Platform has received the Conformité Européenne (CE) Mark of approval.
“The more comprehensive and detailed we can make our data, the better we are able to help people living with peripheral artery disease and other serious conditions in which blood flow to the limbs is impeded,” said Ben Hwang, PhD, chairman and CEO of Profusa. “We designed the Wireless Lumee Oxygen Platform to be small and wearable in order to increase its uptake and use. We believe that the Wireless Lumee Oxygen Platform will especially help realize the promise of remote patient monitoring and digital health applications.”
The Profusa biosensor is approximately 5 mm long and 500 microns in diameter, made of a soft, flexible fiber that mimics the 3D microenvironment of cells, helping it overcome local inflammation or rejection. The biosensor contains a smart gel that is linked to a light-emitting molecule; once excited by the optical reader, it emits a fluorescent light that is proportional to the amount of oxygen measured.
Related Links:
Profusa
The Profusa (Emeryville, CA, USA) Wireless Lumee Oxygen platform consists of a tiny biosensor injected in the upper arm, shoulder, or leg for continuous and long-term monitoring of oxygen in subcutaneous tissue; and a low profile, lightweight wireless optical reader that adheres to the skin, which reads the fluorescent signal from the biosensor and transmits the data to a tablet, which displays real-time data visualization using the proprietary Lumee app. The data monitored includes changes in oxygen levels, comparison of the patient's current data with historical data from a clinical registry study, and a data report.
The data outputs allow physicians to monitor compromised tissue in conditions such as peripheral artery disease (PAD) and critical limb ischemia (CLI), as well as to compare a patient's oxygen levels before, during, and after an endovascular procedure. In contrast to external pulse oximeters, which measure oxygen bound to the hemoglobin in larger blood vessels, it measures dissolved oxygen at the tissue level in interstitial fluid. The Lumee Oxygen Platform has received the Conformité Européenne (CE) Mark of approval.
“The more comprehensive and detailed we can make our data, the better we are able to help people living with peripheral artery disease and other serious conditions in which blood flow to the limbs is impeded,” said Ben Hwang, PhD, chairman and CEO of Profusa. “We designed the Wireless Lumee Oxygen Platform to be small and wearable in order to increase its uptake and use. We believe that the Wireless Lumee Oxygen Platform will especially help realize the promise of remote patient monitoring and digital health applications.”
The Profusa biosensor is approximately 5 mm long and 500 microns in diameter, made of a soft, flexible fiber that mimics the 3D microenvironment of cells, helping it overcome local inflammation or rejection. The biosensor contains a smart gel that is linked to a light-emitting molecule; once excited by the optical reader, it emits a fluorescent light that is proportional to the amount of oxygen measured.
Related Links:
Profusa
Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Bronchoscope
EB-500
Latest Critical Care News
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration
Channels
Artificial Intelligence
view channel
AI-Powered Algorithm to Revolutionize Detection of Atrial Fibrillation
Atrial fibrillation (AFib), a condition characterized by an irregular and often rapid heart rate, is linked to increased risks of stroke and heart failure. This is because the irregular heartbeat in AFib... Read more
AI Diagnostic Tool Accurately Detects Valvular Disorders Often Missed by Doctors
Doctors generally use stethoscopes to listen for the characteristic lub-dub sounds made by heart valves opening and closing. They also listen for less prominent sounds that indicate problems with these valves.... Read more
Surgical Techniques
view channel
Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors
Grade III or IV gliomas are among the most common and deadly brain tumors, with around 20,000 cases annually in the U.S. and 1.2 million globally. These tumors are very aggressive and tend to infiltrate... Read more.jpg "Image: The robotic bronchial endoscope system is designed to treat individuals with obstructed airways (Photo courtesy of KIMM)")
Cutting-Edge Robotic Bronchial Endoscopic System Provides Prompt Intervention during Emergencies
A novel robotic bronchial endoscopic system has been developed to minimize side effects and provide timely intervention for airway obstructions caused by food or foreign bodies in infants, young children,... Read more
Patient Care
view channel
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read more
Health IT
view channel
Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients
Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Strategic Collaboration to Develop and Integrate Generative AI into Healthcare
Top industry experts have underscored the immediate requirement for healthcare systems and hospitals to respond to severe cost and margin pressures. Close to half of U.S. hospitals ended 2022 in the red... Read more
AI-Enabled Operating Rooms Solution Helps Hospitals Maximize Utilization and Unlock Capacity
For healthcare organizations, optimizing operating room (OR) utilization during prime time hours is a complex challenge. Surgeons and clinics face difficulties in finding available slots for booking cases,... Read more
AI Predicts Pancreatic Cancer Three Years before Diagnosis from Patients’ Medical Records
Screening for common cancers like breast, cervix, and prostate cancer relies on relatively simple and highly effective techniques, such as mammograms, Pap smears, and blood tests. These methods have revolutionized... Read morePoint of Care
view channel
Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing
Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Point of Care HIV Test Enables Early Infection Diagnosis for Infants
Early diagnosis and initiation of treatment are crucial for the survival of infants infected with HIV (human immunodeficiency virus). Without treatment, approximately 50% of infants who acquire HIV during... Read more
Whole Blood Rapid Test Aids Assessment of Concussion at Patient's Bedside
In the United States annually, approximately five million individuals seek emergency department care for traumatic brain injuries (TBIs), yet over half of those suspecting a concussion may never get it checked.... Read more
New Generation Glucose Hospital Meter System Ensures Accurate, Interference-Free and Safe Use
A new generation glucose hospital meter system now comes with several features that make hospital glucose testing easier and more secure while continuing to offer accuracy, freedom from interference, and... Read moreBusiness
view channel
Johnson & Johnson Acquires Cardiovascular Medical Device Company Shockwave Medical
Johnson & Johnson (New Brunswick, N.J., USA) and Shockwave Medical (Santa Clara, CA, USA) have entered into a definitive agreement under which Johnson & Johnson will acquire all of Shockwave’s... Read more
